Preview Mode Links will not work in preview mode

The Aliquot Preview

Apr 30, 2021

Traditional vaccines take many years to develop. A recent innovation in vaccine technology involves exploitation of messenger RNA, or mRNA, to facilitate rapid scaling of vaccines and expedite their modification if the virus mutates significantly. The Pfizer and Moderna COVID-19 vaccines capitalize on this technology to induce antibody production against the SARS-CoV-2 virus. 

In this episode, we discuss:
  • (00:00) Introduction
  • (01:31) The difference between the mRNA and traditional vaccines
  • (06:29) Real vaccine side effects known to exist (and why Dr. Seheult believes that the benefits outweigh the risk)
This Aliquot segment features Dr. Roger Seheult, a quadruple board-certified physician serving on the front lines of COVID-19 care and co-founder of MedCram. 
You can see the original full interview with Dr. Seheult 
Get more Aliquots! Become a FMF Premium member and get full access to our members-only podcast, The Aliquot, plus live Q&As with Rhonda, biweekly Science Digest emails, and more.
Learn more and sign up at: